The ongoing pandemic is disrupting research institutes and universities across the world. The institutions are also working hard to find out how the virus can be stopped and its effects mitigated. Below is a list of several possibilities in the U.S. to apply for R&D funding. They vary from purely clinical research to the investigation of the effect of Covid-19 in humanitarian settings.
A call from David Clark Cause and IBM for open source solutions that make an immediate and lasting impact.
The Biomedical Advanced Research and Development Authority’s (BARDA) Broad Agency Announcement (BAA) aimed at products to diagnose, prevent or treat Covid-19 infections.
BARDA’s Division of Research, Innovation & Ventures’ Easy Broad Agency Announcement aimed at diagnostic assays, screening and model development, vaccines, advanced manufacturing.
DARPA’s Office-wide BAA’s on for example Biological Technologies and Information Innovation.
NSF is accepting proposals to conduct non-medical, non-clinical-care research.
Fast Funding for Covid-19 science.
Contribute to the Department of Energy’s work with COVID-19 response and recovery.
The Agency for Healthcare Research and Quality, AHRQ, present a New Funding Opportunity Announcement to support novel, high-impact studies evaluating health system and healthcare professional responsiveness to COVID-19.
A call for research to support Covid-19 response in humanitarian settings from the global charity Elrha.
Topics of specific interest for the National Heart, Lung, and Blood Institute, NHLBI, include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.
Amazon’s Diagnostic Development Initiative (DDI) provides support for innovation in rapid and accurate patient testing that can be done at home or at a clinic with same-day results.
National Center for Advancing Translational Sciences (NCATS) is interested in projects that for instance are focusing on the use of informatics solutions to diagnose cases.
MIT Solve is seeking tech innovations that can slow and track the spread of an emerging outbreak
A call from NIAID for applications from projects focused on preclinical development of lead candidate therapeutics or vaccines that address some emerging infectious diseases including SARS-CoV-2.
Another call for projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2
In addition, Johns Hopkins University has an updated list of funding opportunities specific for Covid-19. Read more about the opportunities here.
Nora Myrne Widfors & Henric Johnson